Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy

Clinical trial NCT04912843 · RECRUITING

Trial details

NCT number: NCT04912843
Sponsor: Wuhan Neurophth Biotechnology Limited Company
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Leber's Hereditary Optic Neuropathy (LHON)

Start date: 2021-06-18
Primary completion: 2024-02-29
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.